quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:52·1812d
INSIDERFiling
GW Pharmaceuticals Plc logo

SEC Form 4: Snyder Douglas B. returned 61,848 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units

GWPH· GW Pharmaceuticals Plc
Health Care
Original source

Companies

  • GWPH
    GW Pharmaceuticals Plc
    Health Care

Related

  • PR583d
    IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel
  • NEWS1204d
    Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
  • NEWS1590d
    Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment
  • SEC1803d
    SEC Form 15-12B filed by GW Pharmaceuticals Plc
  • INSIDER1812d
    SEC Form 4: Tovey Christopher J. returned 2,496 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
  • INSIDER1812d
    SEC Form 4: Cline Darren S returned 5,556 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
  • INSIDER1812d
    SEC Form 4 filed by GRYSKA DAVID W
  • INSIDER1812d
    SEC Form 4: Giacobello Scott M. returned 165,108 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022